Rebalix
Xtrackers · sheet of 10 September 2026
Xtrackers · sheet of 10 September 2026ETF sheet · official issuer and register data
Xtrackers Msci Europe Health Care UCITS ETF 1c
LU0292103222 · LU0292103222 · EUR · domicile Luxembourg
Equity · Europe · Health careSFDR art. 6 (inferred)
Index tracked: MSCI Europe Health Care 20-35 Capped Index (EUR)
- TER
- 0.17%+ trans. 0.05%
- Fund size
- 340 m EUR
- Tracking difference
- −0.06%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Accumulating
Launch 26 Jun 2007 · costs from the KID as of 2 Sept 2026 · 44 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to reflect the performance of the MSCI Europe Health Care Capped 20-35 Index (index).
DESCRIPTION OF INDEX:
The index is based on the MSCI Europe Health Care Index (Parent Index), which is designed to reflect the performance of shares in large and medium capitalisation companies across certain developed markets in Europe which are classified in the health care sector as per the Global Industry Classification Standard®. The weight of the largest group entity in the…
Performance since series start (in euro) — base 100
26 Jun 2007 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +5.1% |
| 3 years | +5.7% |
| 5 years | +16.3% |
| 10 years | +81.5% |
| Since series start | +293.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 17.17% | 16.60% | 16.18% |
| Max drawdown | −12.34% | −27.29% | −27.29% |
| Sharpe | 0.28 | 0.01 | 0.13 |
| Sortino | 0.42 | 0.01 | 0.18 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0292103222 · LU02921032221
RebalixLU0292103222 · LU0292103222 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +4.07% | +4.15% | −0.08% |
| 2024 | +5.09% | +5.14% | −0.04% |
| 2023 | +10.05% | +10.12% | −0.07% |
| 2022 | −5.70% | −5.61% | −0.09% |
Holdings
Portfolio as declared by the issuer · 2 Sept 2026 · 44 securities · top-10 weight = 76.5%
| Top holdings | Weight |
|---|---|
| 16.3% | |
| 16.0% | |
| 13.3% | |
| 8.0% | |
| 5.6% | |
| 5.3% | |
| 3.5% | |
| 3.0% | |
| 2.9% | |
| 2.7% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
DXSE · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 20 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU0292103222
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU0292103222
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU0292103222 · LU02921032222